I don't understand the FDA point either. Too bad. The

New Post Public Reply Private Reply Replies (3) Message Board
plutonium zeynoc #2077
689
I don't understand the FDA point either.

Too bad. The concept is very easy to understand.

This is my last post, so when I push the button, this is a good bye. All of the geniuses on this board can then talk all about share price. and bash KB because someone has to be to blame for shareholders' stock buying decisions.

In my humble opinion, when share price is all that is important, the posters become disconnected from the company and business DECN. Some never cared and it was always about share price. Nonetheless zeynoc I will explain the FDA issue for you.

DECN is demanding $400 - $700 million from J&J. Part of that demand results from a well founded belief that DECN's patents are being infringed by J&J's OneTouch Ultra and OneTouch Select diabetic test strips. OneTouch Select only sells in international markets. How stupid is that plan? Why would anyone sell a product internationally without developing a domestic market. Stupid, stupid, stupid. But for all of that stupidity J&J can be dumb all they want and continue to collect $300 million each year from primarily third world buyers for their OneTouch Select products. But I digress.

I have read all of the pleadings in four Federal lawsuits between DECN and J&J. Throughout all of those 6+ years of pleadings, J&J has played their message board theme: DECN sucks. Mr. Berman is a crook. DECN shareholders hate DECN, so any customers DECN has probably hate them too. DECN has no money and what money they do have was extorted from shareholders. Of the almost 700 Federal filings in these four Federal lawsuits, roughly 475 were filed by J&J and within all of those documents, the iHub message board opinions of DECN are manifest.

And now we come to Monday. Dr. Zem posted that there will be a hearing in Nevada Federal court. That much unfortunately is not true. At a hearing the lawyers, principals and attendees can see how the judge reacts to the pleadings and the oral arguments. At a hearing the judge might just dismiss the J&J Motion and force the litigants into Mediation. But alas, that is not the case. J&J will file their pile of steaming poop, and the judge will take until proobably the end of October to rule. So, what is true is that J&J gets one more written shot at convincing the judge that DECN sucks, Mr. Berman is a crook. DECN shareholders hate DECN, so any customers DECN has probably hate them too. DECN has no money and what money they do have was extorted from shareholders. And that is it. One lonely chance to overcome impossible (at this stage) odds.

I know that J&J will fail at this attempt. The lawyers for both sides know. The judge and his clerks (the real review professionals) all know this and have already made up their minds. The case will proceed, and the parties will be ordered to Mediation.

But my share price paramount friend zeynoc. Do you think the outcome of the Motion will be acceptable to J&J? Their goal is to drag the case out, lower their exposure (they believe time and foot dragging lowers liability -- and they may be right). Monday begins the first BIG strategic event. J&J has known since August 28 they were going to lose the Motion, and all that goes with it.

Court rulings are very, very important. J&J is going to lose this one and this one is BIG, but J&J is still J&J. So, if J&J's plan is to paint DECN like message board posters do: DECN sucks, Mr. Berman is a crook. DECN shareholders hate DECN, so any customers DECN has probably hate them too. DECN has no money and what money they do have was extorted from shareholders, etc. etc. then they are not going to just give up. The court case may move to third gear, but J&J's goal of destroying DECN has not changed.

So here comes the BIG point. What can J&J do that would have the same desired effect. that is, what can J&J do to force DECN to spend big money to survive. What can they do? They can go directly to the post-market group at the FDA and twist them against DECN like on steroids. And that would have the biggest desired effect because the J&J complaints (read: lies) are totally confidential. And the FDA would be only too happy to help out J&J, because FDA people in their mid to late-30s always look to move from the colorless government directly to the private sector, and what better place to work than J&J.

Now zeynoc, you have your own views about how the world works. But in these matters I actually have first hand experience -- many times over. Do you understand THAT? This will become all about the DARK SIDE of the industry if J&J loses in court. Take it to the bank, count on it.

So, let's do whatever we can to force out the only guy who beat J&J and the J&J influenced FDA. and that, in the share price paramount world would be justice. Let's force out the CEO and focus on the share price for the 90 days the company would have to live. I truly hope one or more shareholders come in and take over the company. I am a retired guy and I can afford my loss on DECN stock, so I would love to be a voyeur if shareholders move to force KB out and focus the company on share price.

And with that. Good bye.



1

Decision Diagnostics Corp (DECN) Stock Research Links

DECN Board Company Profile Buy Rating Time & Sales News Filings Financials
Scroll down for more posts ▼

Top 10 Most Recent News Articles

Pollo Campero Unveils Bold New Sauces Nationwide

Updated Category News Views 78

New Sauces Add Flavor Punch to Pollo Campero's Offerings Some days, you're just in the mood to shake things up. That's likely the thinking at Pollo Campero with their latest move: rolling out a trio of sauces that promises to give the taste buds something to talk about. These aren't just any sauces, mind you—this is a strategic gem from the chicken joint known for...

Continue Reading
Princess Cruises Plots Grand Odyssey for 2028–29 Season

Updated Category News Views 25

Princess Cruises: Setting Sail for Uncharted Waters We're not talking about your regular trips along the coast. Princess Cruises is rolling out the anchor for what's set to be a jaw-dropping season in Australia and New Zealand come 2028–29. Now, I know these cruise folks love a grand unveiling, but this one is something else. They've got the longest ever roundtrip World...

Continue Reading
Heart Attack vs. Cardiac Arrest: Know the Differences

Updated Category News Views 31

Spotting the Crisis: Heart Attack or Cardiac Arrest? When your heart’s in trouble, knowing whether it’s a heart attack or cardiac arrest isn’t just some medical trivia—it could save a life. According to healthcare whiz Justin Doss from Beaumont, Texas, this difference can be the thin line between life and a dire outcome. What's the Deal with These Heart Events?...

Continue Reading
Beacon AI's Murdock Flies into the Future for USAF

Updated Category News Views 54

Advancing AI in the Skies Nothing quite shakes up the aviation scene like a debut flight of a new AI system aboard real-deal military planes. Beacon AI is throwing down its AI pilot assistant system, Murdock, on the table—its pride and joy just completed five flights on KC-46A Pegasus craft, sanctioned by no less than the U.S. Air Force itself. Grit and Innovation: The...

Continue Reading
Trip.com Drives Sustainability with New Travel Impact Tool

Updated Category News Views 284

Sustainability Takes Center Stage in Travel Plans So here's the deal: Traveling isn't just about snapping pictures of breathtaking views or rounding up souvenirs anymore. These days, people are increasingly keen on ensuring their trips don't leave a hefty carbon footprint. With the release of Trip.com's 2026 Sustainable Travel Consumer Report, it's clear that the winds...

Continue Reading
Gilded Dragonfly Gallery: A Jewel in Brunswick's Crown

Updated Category News Views 38

There's something remarkable happening in Brunswick, Maryland. This small town's stirring to life with a splash of creativity, and it's just gotten a little brighter with the grand opening of the Gilded Dragonfly Gallery. This isn't just another art gallery popping up; it's a statement of transformation, from quiet exurbia to a thriving arts destination. Jayme Marshall:...

Continue Reading
Vero Beach's Soaring Popularity: A Real Estate Surge?

Updated Category News Views 82

Vero Beach: A Rising Star in Travel Trends Who would've thought Vero Beach, that quiet escape with a nod to old-school Florida, would suddenly find itself in the spotlight? Skyscanner's Travel Trends report thrusts this charming coastal town to the top of the list for 2027, ahead of hotspots like Bimini and Olbia. An impressive 201% increase in flight searches has...

Continue Reading
Philips’ Beauty Tech Trends Promise Intimacy by 2027

Updated Category News Views 146

Beauty Tech Takes a Personal Turn It's 2026, and in the beauty industry, folks are trading flashy for the intimate and intelligent. Philips, that stalwart of tech innovation, is waving the banner, revealing three beauty trends we can't ignore if we plan to keep up with the times. The Rise of Intelligent Guidance First off, everyone and their dog seems to ask how tech is...

Continue Reading
Ecopetrol Sets Q3 2026 Results Release, Conference Call

Updated Category News Views 0

Big Day Incoming: Ecopetrol's Q3 Results Alright, folks, buckle up because Ecopetrol is about to drop its third-quarter numbers for 2026. On November 10th, after the bell, Ecopetrol S.A. (BVC: ECOPETROL; NYSE: EC) will lift the veil on its financial and operational performance. Make sure you got your calendars marked, and better yet, your browser's up to date. Nothing's...

Continue Reading
Etisalat Surges: Net Profit Soars 46% Amid Growth

Updated Category News Views 91

Etisalat's Stellar Performance: A Deeper Dive When a company like Etisalat drops news of a whopping 46% increase in net profit year-over-year, you sit up and pay attention. Those numbers aren’t just a flash in the pan; they're the result of some serious strategic maneuvers and ripe market conditions. Etisalat isn't resting on its laurels, and their latest financials...

Continue Reading

Top 5 Most Recently Viewed Articles

CompTIA's Cybersecurity Viability Session at TechNet Augusta

Updated Category News Views 167

CompTIA's Upcoming Session at TechNet Augusta Conference CompTIA is set to present a significant session at the upcoming TechNet Augusta conference, focusing on how people, data, and artificial intelligence (AI) can come together to enhance the readiness of cybersecurity. This session is an integral part of the CompTIA Learning Solutions Series, scheduled for a day...

Continue Reading
Laura Mercier Launches on Amazon: A New Era of Beauty

Updated Category News Views 2524

Laura Mercier Launches on Amazon Premium Beauty Award-winning beauty brand Laura Mercier has officially launched on the Amazon U.S. Premium Beauty Store, enhancing accessibility to high-quality beauty products. Renowned for its artistry-inspired makeup and skincare lines, Laura Mercier is now joining forces with Amazon, making it easier for beauty enthusiasts everywhere...

Continue Reading
Truist Adjusts Merck's Stock Target Amid Acquisition Insights

Updated Category News Views 121

Truist Adjusts Merck's Price Target Recently, Truist Securities revised its price target for Merck & Co., Inc. (NYSE:MRK) from $143.00 down to $132.00. Despite this adjustment, they continue to maintain a Buy rating for the stock, showcasing their confidence in its long-term potential. Impact of the Recent Acquisition This downgrade comes on the heels of Merck's...

Continue Reading
Xilio Therapeutics Expands Team with Stock Options Grant

Updated Category News Views 174

Xilio Therapeutics Expands Team with Stock Options Grant Xilio Therapeutics, Inc. (Nasdaq: XLO), a cutting-edge biotechnology firm focused on developing tumor-activated immuno-oncology therapies, is making significant strides in its mission to support those living with cancer. In an exciting development, the company has announced the granting of a non-qualified stock...

Continue Reading
Crunching the Numbers: Navigating Portugal’s Mortgage Landscape for Smart Investments

Updated Category Investing Views 527

For the analytical investor, every property acquisition begins with the numbers. In Portugal, a market celebrated for its steady growth and robust financial incentives, understanding mortgage dynamics is essential to making sound investment decisions. You might find that a deep dive into Portugal’s mortgage landscape reveals both challenges and substantial...

Continue Reading